AT403715T

Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs

Abstract

The present invention provides a recombinant adeno-associated virus (rAAV) virus preparation, which rAAV virus preparation is essentially free of other viruses, comprising an rAAV vector, wherein the rAAV vector comprises a single-stranded heterologous nucleotide sequence comprising a coding region which forms intrastrand base pairs such that expression of the coding region of the heterologous sequence is enhanced relative to an rAAV vector that lacks sufficient intrastrand base pairing to enhance said expression, wherein the rAAV vector comprises one or more inverted terminal repeat (ITR) sequences flanking said heterologous sequence, wherein the rAAV vector is less than 2.5 kilobases in length, wherein the total amount of unique sequence present in the heterologous sequence is about one-half of the heterologous sequence and wherein the heterologous sequence forms intrastrand base pairs along most or all of its length, for use in a method of treatment of the human or animalbody by therapy.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

39 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
16008099United States of AmericaP

Members39

Family members, oldest first
DocumentOfficeKind
CA2379166A1CanadaA1
WO0111034A2World Intellectual Property Organization (WIPO)A2
AU6626500AAustraliaA
WO0111034A3World Intellectual Property Organization (WIPO)A3
EP1204739A2European Patent Office (EPO)A2
JP2003506083AJapanA
US6596535B1United States of AmericaB1
US2003219735A1United States of AmericaA1
AU781958B2AustraliaB2
AU781958CAustraliaC
US7125717B2United States of AmericaB2
US2007087433A1United States of AmericaA1
EP1916258A2European Patent Office (EPO)A2
EP1204739B1European Patent Office (EPO)B1
AT403715TThis recordAustriaT
US2008206197A1United States of AmericaA1
DE60039766D1GermanyD1
DK1204739T3DenmarkT3
PT1204739EPortugalE
ES2308989T3SpainT3
EP1916258A3European Patent Office (EPO)A3
JP2010172349AJapanA
US7785888B2United States of AmericaB2
US7846729B2United States of AmericaB2
US2011104117A1United States of AmericaA1
EP2369002A1European Patent Office (EPO)A1
JP4827353B2JapanB2
US8093054B2United States of AmericaB2
US2012184602A1United States of AmericaA1
CY1107432T1CyprusT1
CA2379166CCanadaC
JP5277427B2JapanB2
EP1916258B1European Patent Office (EPO)B1
ES2478635T3SpainT3
DK1916258T3DenmarkT3
PT1916258EPortugalE
US2016168589A1United States of AmericaA1
CY1115408T1CyprusT1
US2019100773A1United States of AmericaA1